Expression and secretion of functional miniantibodies McPC603scFvDhlx in cell-wall-less L-form strains of Proteus mirabilis and Escherichia coli : A comparison of the synthesis capacities of L-form strains with an E. coli producer strain
Authors:
- 26 January 1998
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 49 (1) , 51-58
Abstract
The paper describes the synthesis of the phosphorylcholine-binding miniantibody McPC603scFvDhl x in cell-wall-less L-form strains of Escherichia coli and Proteus mirabilis. Cells of these strains were transformed with the plasmid pACK02scKan, carrying the miniantibody (miniAb) coding sequence under the control of the lac promoter. L-form transformants of both species were able to synthesize the functional miniAb as an extracellular soluble product. The highest quantities were obtained by P. mirabilis L-form strains after induction with 5 mM isopropyl β-d-thiogalactopyranoside (IPTG). Yields of 45–75 mg/l total antibody protein and of 10–18 mg/l functional miniAb were estimated in the growth medium of shaking cultures 40–80 h after induction with IPTG. About 10% of the active miniAb remained cell-bound. The yields of functional miniAb could be optimized by lowering the growth temperature from 37 °C to 26–32 °C and by supplementation of the medium with 80 mM sodium fumarate. A comparison of the specific activities revealed that the P. mirabilis L-form strains have a similar synthesis capacity (2–4 mg functional miniAb/g cell dry weight) to that of the producer strain E. coli RV308. The results show that the processes of correct folding and assembling of the miniAb molecules are possible without the periplasmic compartment.Keywords
This publication has 10 references indexed in Scilit:
- High volumetric yields of functional dimeric miniantibodies in Escherichia coli , using an optimized expression vector and high-cell-density fermentation under non-limited growth conditionsApplied Microbiology and Biotechnology, 1996
- Improved Bivalent Miniantibodies, with Identical Avidity as Whole Antibodies, Produced by High Cell Density Fermentation of Escherichia coliNature Biotechnology, 1993
- High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody FragmentNature Biotechnology, 1992
- A comparison of strategies to stabilize immunoglobulin Fv-fragmentsBiochemistry, 1990
- Glucose as a substrate in recombinant strain fermentation technologyApplied Microbiology and Biotechnology, 1989
- Complete secretion of activable bovine prochymosin by genetically engineered L forms of Proteus mirabilisApplied and Environmental Microbiology, 1989
- Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coliScience, 1988
- Physiological constraints in increasing biomass concentration ofEscherichia coli B in fed-batch cultureBiotechnology Letters, 1987
- STRUCTURE OF THE PENICILLIN ACYLASE GENE FROM ESCHERICHIA-COLI - A PERIPLASMIC ENZYME THAT UNDERGOES MULTIPLE PROTEOLYTIC PROCESSING1985
- Gene regulation at the right operator (OR) of bacteriophage λJournal of Molecular Biology, 1980